FDA Probe Could Grow To Encompass Fresenius Empire
The U.S. Food and Drug Administration confirmed Friday it was investigating Fresenius Medical Care North America's decision to alert company-affiliated physicians of cardiac risks linked to a dialysis treatment months before...To view the full article, register now.
Already a subscriber? Click here to view full article